INTRODUCTION
Heme, which is mainly derived from hemoglobin (Hb), is a strong oxidant and has potent pro-inflammatory properties. These properties become apparent if the intricate intraerythrocytic compartmentalization of heme is compromised following the destruction of erythrocytes. [1] [2] [3] [4] Large quantities of free hemoglobin can be found in the circulation of individuals who have been transfused with cell-free hemoglobin products as a blood substitute. 5 Macrophages are the primary scavengers of Hb following systemic hemolysis and during wound healing. These cells also play a key role in the clearance of exogenously administered blood substitutes. 6 CD163 is a member of the cysteine-rich scavenger receptor family, and is exclusively expressed by cells of monocyte/macrophage lineage. 7 Resident tissue macrophages contain the highest levels of CD163, most notably Kupffer cells in the liver and macrophages within the bone marrow and spleen red pulp. [8] [9] [10] To date, the Hb-haptoglobin (Hp) complex is the only known ligand of CD163 11, 12 and neither Hp alone nor free Hb have been found to display high-affinity binding to the receptor. Because the Hb-Hp complex binds to CD163
with high affinity and the receptor system has a high endocytotic capacity, CD163 is thought to mediate clearance of Hb-Hp complexes from the blood. 13 Several lines of evidence indicate that CD163 plays a key role in the antiinflammatory and wound-healing process. First, there is a high level of CD163 expression by macrophages during the down-regulatory phase of inflammatory reactions. 8, 14 Second, CD163 expression is strongly induced by glucocorticoids, 15, 16 as well as by the prototypic antiinflammatory cytokine interleukin-10. 17 Accordingly, we have recently demonstrated that glucocorticoid-induced CD163 expression in macrophages enhances their capacity to bind and internalize Hb-Hp complexes. 16 Removal of pro-oxidant and pro-inflammatory Hb may, in fact, be an important function of macrophages during intravascular hemolysis and upon the local release of large quantities of free Hb at sites of injury. However, the rapid decline which occurs in Hp binding capacity during hemolytic anemia, [18] [19] [20] malaria, 21, 22 or local extravascular Hb release, suggests the existence of a highly efficient, but Hp-independent, Hb clearance pathway. Neither Hp knockout mice, 23, 24 nor humans with anhaptoglobinemia 25 display compromised plasma Hb clearance and the cellular distribution of Hb uptake in liver
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The current study examined the CD163-dependent uptake of Hb in greater detail. Our results are consistent with a biphasic model of macrophage-mediated Hb clearance. In this model, small amounts of free Hb are removed by the well characterized, high-affinity interaction of CD163 with the Hb-Hp complex. 11, 12 However, once plasma Hp is depleted, CD163-mediated uptake of free Hb is maintained through an apparently lower-affinity, Hpindependent interaction between free Hb and the macrophage scavenger receptor CD163.
METHODS

Cell culture
Human embryonic kidney cells (HEK293; Invitrogen, Basel, Switzerland) were cultured in DMEM (Invitrogen) containing 10% fetal calf serum (FCS, Invitrogen). The total Hp concentration in the complete culture medium was determined with a recently described bovine-Hp specific ELISA 27 and was 0.29 μg/mL. The total free Hb concentration was estimated by spectrophotometry (A 540 ) and was ≈ 5μg/ml. Therefore, no free Hp binding capacity is expected to be present under these conditions. Cells that had been stably transduced with lentiviral vectors (control or CD163) were propagated in the presence of 5 μg/mL blasticidin (Invitrogen). Blasticidin was removed from cultures at least one cell passage prior to use in experiments.
Human macrophages were prepared from buffy coats of healthy blood donors (Swiss Red Cross blood donation program, Zurich, Switzerland), as described previously. 9 Cells were cultured in IMDM (Invitrogen) supplemented with 20% heat-inactivated, pooled human serum and 20 μg/mL gentamicin (Sigma, Buchs, Switzerland). The medium was replaced on days one and four. On day eight, the medium was changed to IMDM containing 10% FCS.
During this time, the differentiated macrophages took on a uniform, egg-shaped morphology.
Experiments were performed on day ten. Alternatively, monocytes were incubated for 36h
with dexamethasone (Sigma) at a concentration of 2.5x10 -7 M to achieve maximal CD163
expression. 16 For personal use only. 
16,28
Quantification of Hb-Hp uptake by macrophages and HEK293 cells
HbA 0 (Sigma) or Hp phenotype 2-2 (Sigma) were labeled with the Alexa-488, Alexa-633 or Alexa-647 protein labeling kit (Molecular Probes, Eugene, OR), as described previously. 16 To quantify Hb or Hb-Hp uptake, cells were incubated with the respective ligands in an incubator at 37°C, 5% CO 2 and 95% humidity. All uptake assays were performed in cell culture medium without serum. Hb-Hp complexes were generated by combining Hb and Hp at a 1:1 ratio (w/w), 10 min before experimentation. 
RNA isolation and quantitative real-time reverse transcription PCR (RT-PCR)
Total cellular RNA was isolated using the QIAgen RNAeasy Mini Kit (Qiagen, Basel, Switzerland) which included a DNAse digest. Total RNA was quantified spectrophotometrically, and equal amounts of RNA (5 μg) were reverse transcribed into cDNA with oligo(d)T primers and M-MuLV Reverse Transcriptase using the ProSTAR First Strand Kit (Stratagene, Rotkreuz, Switzerland). Duplicates of cDNA were amplified by RT-PCR with gene-specific primers using the LightCycler® System (Roche Diagnostics Basel, Switzerland) and the Fast Start DNA Master SYBR Green I (Roche Diagnostics), as described previously. 9 The sequence-specific primers were selected using PrimerDesign software The final data were expressed as mRNA expression in treated cells relative to the expression level in untreated cells. A melting curve analysis was performed for each amplicon to determine the specificity of each amplification, and the amplification products were sequenced to determine target specificity (Microsynth, Switzerland).
Modified hemoglobin solutions
Highly purified human Hb (HbA 0 ) was obtained from Hemosol (Ontario, Canada). Modification of the βCys93 of αα-DBBF-Hb was performed according to Boykins et al. 29 The purified di-amino bromoacetyl peptide (H-Lys(Lys) 2 For personal use only. on October 22, 2017. by guest www.bloodjournal.org From
Purification of Oxyglobin
® fractions
The heterogeneous mixture that comprises Oxyglobin® was separated into four distinct and homogeneous fractions using a Bio-Sil-TSK-250 (600 mm x 7.5 mm) sizeexclusion column (Bio-Rad Laboratories Inc., Hercules, CA) attached to a Waters 626 pump and Waters 2487 dual wavelength detector, all controlled by a Waters 600s controller using Millenium32 software (Waters Corp., Milford, MA). The running buffer, 0.1M NaH 2 PO 4 (pH 6.5), was pumped at a rate of 0.5 mL/min; absorbance was monitored at 214 and 280 nm.
Fractions were collected on a Spectra/Chrom CF-1 fraction collector (Spectrum Laboratories 
Preparation and purification of hemoglobin CNBr digest fragments
HbA 0 was digested with cyanogen bromide (CNBr) (Sigma-Aldrich Chemicals, St.
Louis, MO). Briefly, CNBr was prepared in 70% formic acid and added to HbA 0 in sufficient quantity to make up a 50-fold molar excess of the methionine content within HbA 0 . The mixture was allowed to react at ambient temperature for 16 hours after which time the mixture was frozen at -80°C and lyophilized. The lyophilized HbA 0 peptide mixture was dissolved in 0.1% trifluoroacetic acid (TFA) and separated using a Vydac protein/peptide (250 mm x 4.6 mm) analytical C18 column (Vydac, Columbia, MD). The Waters HPLC system described previously was used pumping a gradient of A: 0.1% TFA and B: 100% acetonitrile at a rate of 1 mL/min increasing B from 0% to 70% over 50 minutes. The separation of peptides was monitored at a wavelength of 214 nm and like peaks pooled over several on column injections. Identification of collected peptides was performed by MALDI-MS with comparison of experimental and theoretical MS data to confirm the identity of peptides.
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From
Statistical analysis
Results are expressed as mean ± SD and are derived from multiple independent experiments, as indicated in the figure legends. Error bars were omitted where SDs were too small to be properly displayed. Data were analyzed by one-way analysis of variance (ANOVA) and appropriate post tests were carried out using GraphPad Prism 4.0 software. A value of P<0.05 was accepted as statistically significant.
RESULTS
CD163 mediates endocytosis of free Hb in the absence of Hp
We used CD163-transduced HEK293 cells and fluorescent ligand assays to study the interaction of CD163 with purified hemoglobin. In accord with earlier studies, CD163- We have excluded endogenous synthesis and secretion of Hp by the HEK293 cell lines used throughout these studies by analyzing cell lysates and cell culture supernatant by Western-Blot using a polyclonal antibody against human Hp. The sensitivity of the WesternBlot was determined to be between 0.1 ng -1 ng (see supplemental Figure 1A ). The possibility that Hb preparations were inadvertently contaminated with Hp was discounted by analyzing each Hb preparation using a biochip protein assay. The analytical sensitivity for the detection of Hp was determined to be well below 1% of the total protein (see supplemental Figure 1B ). Furthermore, no free Hp binding capacity existed in our culture medium containing 10% FCS: the minute amount of bovine Hp (0.29 μg/mL) was irreversibly blocked by the free Hb present in FCS, which exceeded the Hp concentration by more than tenfold.
Substantially lower concentrations of these contaminants were present during the endocytosis assays which were all performed in serum free medium after thorough washing of cells with PBS. Also, to exclude the possibility that non-specific CD163-Hb interactions occurred due Hb-Hp uptake, in comparison to native Hb, may be explained by the stable tetrameric conformation of the molecule. However, the much stronger inhibition of Hb-Hp uptake by αα-DBBF-Hb-MPC was unexpected ( Figure 3C ). Quantitatively, the competitive inhibition of Hb-Hp uptake exerted by αα-DBBF-Hb-MPC equals that exhibited by the Hb-Hp complex ( Figure 3D ). Alexa-633 labeled αα-DBBF-Hb and its derivative were endocytosed by CD163-positive, but not by CD163-negative, cells; uptake was completely inhibited by a (Figures 3E-F) . Thereby, as expected from the competitive inhibition experiments, CD163 mediated endocytosis of αα-DBBF-Hb-MPC appeared to be as efficient as the uptake of Hb-Hp complex ( Figure 3E ).
These data indicate that the nature and potentially the site(s) of chemical modifications to Hb based blood substitutes may directly influence their distribution, metabolism and elimination.
Hb polymerization impairs uptake by CD163
Next, we assessed the impact of Hb polymerization on its interaction with CD163.
Oxyglobin® is an Hb-based oxygen carrier that is composed of polymerized bovine Hb. 32 We chromatographically purified the four main fractions and assessed their effect on CD163- 
Role of the C-terminal Hb β-chain in CD163-Hb interaction
In an attempt to characterize the peptide region of Hb involved in the CD163-Hb Figure 5C ). These data suggest independent regions in Hb to be responsible for Hp and 
Human macrophages endocytose native and α−α crosslinked Hb by the CD163 pathway
Finally, we examined CD163-Hb interactions in cultured human macrophages.
Antibody labeling and FACS analysis revealed low levels of CD163 cell-surface expression on freshly isolated monocytes ( Figure 6A) ; the density of CD163 increased more than 20-fold during a culture period of eight days. Accordingly, the uptake of free Hb paralleled this increase in CD163 cell surface expression. Addition of a polyclonal rabbit IgG directed against human CD163 almost completely inhibited free Hb endocytosis; but, this was not the case when non-immune rabbit serum was added (data not shown) ( Figure 6A ). As was demonstrated with HEK293 cells, Hb-Hp complexes and free Hb (but not free Hp), significantly inhibited the uptake of fluorescent Hb-Hp. The uptake characteristics of free Hb in macrophages are, therefore, comparable to those observed in CD163-HEK293 cells, with approximately 70% inhibition of Hb-Hp uptake being observed with a 100-fold excess of unlabeled Hb (supplemental Figure 2) . The dose-response curves shown in Figure 6B demonstrate the critical impact of Hp-complex formation on Hb uptake by macrophages at low ligand concentrations (1 μg/mL). However, at higher ligand concentrations (100 μg/mL), there is no difference between the uptake of Hb-Hp and free Hb.
Prior to uptake-studies, performed in serum-free media, primary human monocytederived macrophages must be cultured in the presence of human serum containing Hp. Thus, in order to prove Hp-independence of Hb endocytosis in macrophages, we determined the uptake of non-Hp-binding α−α crosslinked Hb. As seen in Figure 7 Our results apparently contradict previous studies (Kristiansen et al. 11 and Asleh et al. 34 ) which described CD163 as a specific receptor for Hb-Hp complexes but not for free Hb.
The experiments presented in our study focused on the biological end-points of CD163-mediated Hb endocytosis and induction of the heme breakdown pathway. Kristiansen et al. 11 and Asleh et al., 34 however, attempted to determine putative high affinity, physical interactions between free Hb and CD163 in binding studies which employed either CD163-expressing cell lines 34 or immobilized receptor. 11 In line with these studies, we also failed to detect high affinity binding of Hb to CD163-expressing cells when using classical binding assays, which measure receptor associated ligand following prolonged incubation of ligand The uptake of free Hb by CD163 described here may become relevant once Hp binding capacity has been depleted by massive hemolysis or upon extravasation of erythrocytes. Indeed, we found that macrophage Hb uptake is significantly enhanced by Hp at low Hb concentrations of 1 μg/mL, but not at concentrations above 100 μg/mL. These higher concentrations can be observed following intravascular hemolysis 25, 35 ; even higher concentrations of free Hb accumulate at sites of tissue injury due to erythrocyte extravasation.
In light of the results presented here, a biphasic model of free Hb clearance by macrophages is proposed. When concentrations of free Hb are low, such as during mild intravascular hemolysis, Hb is rapidly sequestered by circulating Hp. The resulting Hb-Hp complexes are cleared from the circulation by high-affinity binding to, and uptake by, CD163-expressing macrophages in the liver, spleen and bone marrow. This high-affinity pathway is operative as long as the Hp binding capacity is higher than the total amount of Hb released from bursting erythrocytes. However, following more pronounced, systemic hemolysis plasma Hp is rapidly depleted, in some cases rendering it undetectable. Low to undetectable plasma Hp levels are, therefore, a sensitive marker of hemolysis in clinical practice. 18 We propose that free Hb clearance by macrophages under these circumstances is mediated by an Hp-independent CD163-Hb interaction. This Hb clearance mechanism is even more applicable at sites of tissue injury where large amounts of Hb must be removed by 
